ICD Therapy for Primary Prevention in Hypertrophic Cardiomyopathy.

about

Divergent effect of adrenaline in human induced pluripotent stem cell derived cardiomyocytes obtained from hypertrophic cardiomyopathy.Letter to the Editor: Contemporary Screening and Treatment of Hypertrophic Cardiomyopathy.

P2860

Q48183741-79BF5229-06A2-47F8-855F-5618AD2F77B1 Q55005588-EC24876E-D789-4581-9577-D55DA7C4653B

P2860

ICD Therapy for Primary Prevention in Hypertrophic Cardiomyopathy.

Item

http://www.wikidata.org/entity/Q39003149

description

2016 nî lūn-bûn

@nan

2016 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

name

ICD Therapy for Primary Prevention in Hypertrophic Cardiomyopathy.

@en

ICD Therapy for Primary Prevention in Hypertrophic Cardiomyopathy.

@nl

type

Item

label

ICD Therapy for Primary Prevention in Hypertrophic Cardiomyopathy.

@en

ICD Therapy for Primary Prevention in Hypertrophic Cardiomyopathy.

@nl

prefLabel

ICD Therapy for Primary Prevention in Hypertrophic Cardiomyopathy.

@en

ICD Therapy for Primary Prevention in Hypertrophic Cardiomyopathy.

@nl

P1476

ICD Therapy for Primary Prevention in Hypertrophic Cardiomyopathy.

@en

P2093

Amar Trivedi

http://www.w3.org/2001/XMLSchema#string

Bradley P Knight

http://www.w3.org/2001/XMLSchema#string

P2860

Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia.

Sudden death in hypertrophic cardiomyopathy: identification of high risk patients.

Role of invasive EP testing in the evaluation and management of hypertrophic cardiomyopathy.

Maximum left ventricular thickness and risk of sudden death in patients with hypertrophic cardiomyopathy.

Failure to raise blood pressure during exercise is a poor prognostic sign in patients with hypertrophic non-obstructive cardiomyopathy.

Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Ther

Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.

Syncope and risk of sudden death in hypertrophic cardiomyopathy.

A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD).

2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC).

P304

188-196

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.15420/AER.2016:30:2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28116084

http://www.w3.org/2001/XMLSchema#string

P932

5248664

http://www.w3.org/2001/XMLSchema#string

ICD Therapy for Primary Prevention in Hypertrophic Cardiomyopathy.

about

P2860

P2860

ICD Therapy for Primary Prevention in Hypertrophic Cardiomyopathy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932